LifeStance Health GroupLFST +3.58%56 Graham Number is $0.14 as of Mar. 2026, which is 100% below its 10-year median of 37.42. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.23 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 368 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 100% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
The historical rank and industry rank for LifeStance Health Group's Graham Number or its related term are showing as below:
LFST'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 29.33 Med: 37.42 Max: 77.75
Current: 76.5
During the past 7 years, the highest Price to Graham Number ratio of LifeStance Health Group was 77.75. The lowest was 29.33. And the median was 37.42.
LFST's Price-to-Graham-Number is ranked worse than 100% of 368
companies
in the Healthcare Providers & Services industry
Industry Median: 1.615
vs LFST: 76.50
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
LifeStance Health Group (NAS:LFST) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
LifeStance Health Group's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Mar. 2026 )
=
10.71
/
0.14
=
77.26
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
LifeStance Health Group Graham Number Related Terms
LifeStance Health Group Graham Number Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, LifeStance Health Group's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Price-to-Graham-Number vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a Graham Number of $0.14 as of Mar. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on LifeStance Health Group and its competitors. This is 100% below median its historical median of 37.42. Over the past decade, LifeStance Health Group's Graham Number has ranged from 29.33 to 77.75. According to the industry distribution chart, LifeStance Health Group ranks #368 out of 368 companies in the Healthcare Providers & Services industry.
Is LifeStance Health Group's Graham Number too high?
LifeStance Health Group's current Graham Number of $0.14 is 100% below median its 10-year median of 37.42. Over the past 10 years, this metric has ranged from a low of 29.33 to a high of 77.75. The Healthcare Providers & Services industry median Graham Number is 1.62. LifeStance Health Group's value of $0.14 is 91.3% below this industry median. Based on the distribution chart, LifeStance Health Group ranks #368 out of 368 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Graham Number compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #368 out of 368 companies for Graham Number. This places LifeStance Health Group in the lower half of its industry. The industry median Graham Number is 1.62. LifeStance Health Group's value of $0.14 is 91.3% below this benchmark. Historically, LifeStance Health Group's own Graham Number has ranged from 29.33 to 77.75 over the past decade. While the company's 10-year median is 37.42 vs. the industry median of 1.62, LifeStance Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Healthcare Providers & Services company?
The median Graham Number among Healthcare Providers & Services companies is 1.62, based on 368 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Graham Number of $0.14 is 91.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Graham Number is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Graham Number is $0.14, which is 100% below median its own 10-year median of 37.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.23, compared to a current price of $10.71 — trading 30.1% above its estimated fair value. The current Graham Number is $0.14, which is 100% below median its 10-year median of 37.42 and 91.3% below the Healthcare Providers & Services industry median of 1.62. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Graham Number is $0.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.71 is trading 30.1% above its estimated GF Value™ of $8.23.
GuruFocus considers LifeStance Health Group to be Significantly Overvalued.
Key valuation signals for LFST:
Graham Number: $0.14 (100% below median its 10-year median of 37.42)
GF Value™: $8.23 vs. price of $10.71 (30.1% above fair value)
Industry Position: 91.3% below the Healthcare Providers & Services median (#368 of 368)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
